Skip to main content
. 2020 May 14;45(5):575–586. doi: 10.1007/s13318-020-00624-6

Table 1.

Drug formulation developed by the Monash Institute of Pharmaceutical Sciences (MIPS)

Ingredient Concentration (g/L)

Active

Cannabidiol (CBD)

100.00

Flavours

Neotame (sweetener)

d-limonene (orange flavour)

0.10

0.20

Diluent

Maisine CC (glyceryl monolinoleate)

Super Refined soybean oil

10.00

To 1 L